Table 1.
Patient characteristics and OML uptake by human PBMs and PEMs according to CD14 status
| Cases | Sample | Stage | Cytology | FACS analysis (%) | |||
|---|---|---|---|---|---|---|---|
| CD14 (+) OML (+) | CD14 (−) OML (+) | CD14 (+) OML (−) | CD14 (−) OML (−) | ||||
| Patient 1† | Peritoneal wash | III | − (I) | 60.54 | 8.17 | 15.19 | 16.11 |
| Patient 2 | Peritoneal wash | IV | + (V) | 33.13 | 11.20 | 15.46 | 40.20 |
| Patient 3 | Peritoneal wash | I | − (I) | 28.49 | 5.88 | 42.48 | 23.47 |
| Patient 4 | Peritoneal wash | I | − (I) | 29.49 | 2.08 | 35.61 | 32.82 |
| Patient 5 | Peritoneal wash | II | − (I) | 50.13 | 12.38 | 11.01 | 26.48 |
| Healthy 1‡ | Peripheral blood | NC | NC | 77.90 | 9.54 | 6.60 | 5.96 |
| Healthy 2 | Peripheral blood | NC | NC | 72.57 | 14.39 | 12.57 | 0.74 |
| Healthy 3 | Peripheral blood | NC | NC | 80.84 | 8.23 | 9.03 | 1.90 |
| Healthy 4 | Peripheral blood | NC | NC | 85.23 | 0.86 | 12.60 | 0.54 |
†Peritoneal wash from gastric cancer patients; ‡peripheral blood from healthy volunteers. NC, not classified; OML, oligomannose‐coated liposome; PBMs, peripheral blood monocytes; PEMs, peritoneal macrophages.